2021
DOI: 10.1111/bjd.20894
|View full text |Cite
|
Sign up to set email alerts
|

Targeting CD56 with an antibody–drug conjugate in Merkel cell carcinoma

Abstract: AD more than 11-fold. 1 From a clinical point of view, this is highly important: AD is not just a skin disease but has been shown to be a systemic disease associating with several comorbidities besides other atopic diseases already in children and adolescents. 5,6 As the risk for comorbidities increases with disease severity, it is important to recognize the individuals at highest risk as early as possible. 7 Perhaps in the next decade we will even have the possibility to prevent these comorbidities by treatin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 11 publications
0
0
0
Order By: Relevance